Research News and Research

RSS

Dassault Systèmes announces partnership with echoBase

Dassault Systèmes (DS), a world leader in 3D and Product Lifecycle Management (PLM) solutions, announced today a partnership with application developer echoBase, Inc, marking DS's entry into the electronic medical records market. echoBase's Resonate iPhone application for doctors, hospitals, pharmacies and other healthcare providers will leverage Dassault Systèmes' ENOVIA V6 online collaboration and data management solution to deliver portability, availability and security of healthcare data.

6 May 2010

OUP's Oxford Textbook of Medicine launched online for the first time

Oxford University Press has launched, for the first time online, the prestigious Oxford Textbook of Medicine. Generations of consultants, trainees, and medical students have relied on this "classic" for practical guidance on clinical management and the prevention of disease. Others, such as journalists, authors, and lawyers have used it as the ultimate reference medical book.

6 May 2010

Home-based medical devices to grow over 1.6M by 2013: Report

Emerging Healthcare Solutions, Inc. applauded the results of a new report from InMedica on the world market for telemedicine, predicting that the use of home-based medical devices will drastically increase as telemedicine takes-off. According to the report, by 2013 the combined unit shipments of home-use digital blood-glucose meters, blood pressure monitors, weight scales, pulse oximeters and peak flow meters used in telemedical applications will grow to over 1.6 million.

6 May 2010

Lack of physical activity and greater TV viewing time associated with wider retinal venules

It is well known that the lack of physical activity is a risk factor for cardiovascular diseases, but what part does it play in retinal vascular caliber? A team of researchers examined the association of physical activity and television viewing time with retinal vascular caliber and explored the differences in white, black, Hispanic and Chinese racial/ethnic groups.

6 May 2010

Neuroscientist Snyder presents annual Ellis S. Grollman Lecture at UMB

If a drug was developed to block a key protein linked to the onset of Huntington's Disease, it could have a clear path to the part of the brain most affected by the disease, while not bothering other parts of the brain and body, said distinguished neuroscientist Solomon H. Snyder, MD, to an audience of about 300 students and faculty at the University of Maryland, Baltimore (UMB).

6 May 2010

Research reveals reason for ineffectiveness of antioxidants against cardiovascular disease

A new study by researchers at the Swedish medical university Karolinska Institutet shows that the immune defence's T cells can attack the "bad" LDL cholesterol and thereby cause an inflammation that leads to atherosclerosis. By producing a vaccine against the T cell receptors, the researchers have managed to inhibit the development of atherosclerosis in animals.

6 May 2010

Labopharm's first-quarter fiscal 2010 revenues from product sales decrease $0.4M to $3.2M

Labopharm Inc. today reported its financial results for the first quarter 2010.

6 May 2010

Multistage nanovector system for siRNA delivery lengthens therapeutic effects of ovarian cancer treatment

New research by scientists at The University of Texas Health Science Center at Houston (UTHealth) and The University of Texas M. D. Anderson Cancer Center could make it easier for patients to use a family of promising experimental cancer therapeutics known as small interfering RNA (siRNA).

6 May 2010

Study on risk factors, potential harm associated with medication errors at hospital admission

A recent study conducted at Northwestern Memorial Hospital found that almost 50 percent of medication discrepancies were related to a failure to understand all of the prescription medications patients were taking at the time of hospital admission. While it's common for patients not to recall all of their medications, especially when they are not feeling well or being unexpectedly admitted to the hospital, the results can be serious.

6 May 2010

Ovarian hormone progesterone plays pivotal role in altering breast stem cells: PMH researchers

Cancer researchers at Princess Margaret Hospital have discovered that the ovarian hormone progesterone plays a pivotal role in altering breast stem cells, a finding that has important implications for breast cancer risk.

6 May 2010

Micrus Endovascular reports 24% increase in fourth-quarter neurovascular revenues

Micrus Endovascular Corporation today reported financial results for the three and 12 months ended March 31, 2010 and introduced fiscal 2011 financial guidance.

6 May 2010

Global warming could lead to deadly temperatures for humans in coming centuries: Research

Reasonable worst-case scenarios for global warming could lead to deadly temperatures for humans in coming centuries, according to research findings from Purdue University and the University of New South Wales, Australia.

6 May 2010

IOF WCO-ECCEO10 osteoporosis congress opens in Florence, Italy

A record number of researchers and clinicians from some 100 countries gathered today in Florence, Italy to share new information about osteoporosis, a serious chronic disease which leads to weakened bones and fractures in as many as one in three women and one in five men over the age of fifty.

6 May 2010

Abbott's SPIRIT IV trial results published in The New England Journal of Medicine

Findings from Abbott's SPIRIT IV trial, one of the largest randomized clinical trials comparing two drug eluting stents, with 3,690 U.S.-based patients, were published today in The New England Journal of Medicine.

6 May 2010

CHSS helps Pilgrims Hospices evaluate new service to improve end-of-life care for terminally-ill people

The Centre for Health Services Studies at the University of Kent is helping Pilgrims Hospices evaluate a new service that will improve end-of-life care for terminally-ill people who prefer to remain at home.

6 May 2010

New blood test could increase success of lung cancer drug erlotinib: Study

A new blood test could increase the success of a popular lung cancer drug called erlotinib by allowing doctors select which patients will react positively to the drug.

6 May 2010

Research reveals role of ovarian hormone progesterone in alteration of breast stem cells

Cancer researchers at Princess Margaret Hospital (PMH) have discovered that the ovarian hormone progesterone plays a pivotal role in altering breast stem cells, a finding that has important implications for breast cancer risk.

6 May 2010

CU-Boulder develops inhalable vaccine for measles prevention

A team of researchers led by the University of Colorado at Boulder believe a dry powder, inhalable vaccine developed for measles prevention and slated for human clinical trials later this year in India will lead to other inhalable, inexpensive vaccines for illnesses ranging from tuberculosis to cervical cancer.

6 May 2010

Pharmasset reports net loss of $16.1 million for fiscal second-quarter 2010

Pharmasset, Inc., a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended March 31, 2010.

6 May 2010

Intercell to acquire Cytos' platform technology for monoclonal antibody discovery

Intercell AG today announced that it has signed an agreement with Cytos Biotechnology Ltd. to acquire Cytos' platform technology for monoclonal antibody discovery. The technology is based on expression cloning of monoclonal antibodies from human B-cells and enables the identification of anti-infective antibodies to prevent and treat infectious diseases.

6 May 2010

Research News and Research

Dassault Systèmes announces partnership with echoBase

OUP's Oxford Textbook of Medicine launched online for the first time

Home-based medical devices to grow over 1.6M by 2013: Report

Lack of physical activity and greater TV viewing time associated with wider retinal venules

Neuroscientist Snyder presents annual Ellis S. Grollman Lecture at UMB

Research reveals reason for ineffectiveness of antioxidants against cardiovascular disease

Labopharm's first-quarter fiscal 2010 revenues from product sales decrease $0.4M to $3.2M

Multistage nanovector system for siRNA delivery lengthens therapeutic effects of ovarian cancer treatment

Study on risk factors, potential harm associated with medication errors at hospital admission

Ovarian hormone progesterone plays pivotal role in altering breast stem cells: PMH researchers

Micrus Endovascular reports 24% increase in fourth-quarter neurovascular revenues

Global warming could lead to deadly temperatures for humans in coming centuries: Research

IOF WCO-ECCEO10 osteoporosis congress opens in Florence, Italy

Abbott's SPIRIT IV trial results published in The New England Journal of Medicine

CHSS helps Pilgrims Hospices evaluate new service to improve end-of-life care for terminally-ill people

New blood test could increase success of lung cancer drug erlotinib: Study

Research reveals role of ovarian hormone progesterone in alteration of breast stem cells

CU-Boulder develops inhalable vaccine for measles prevention

Pharmasset reports net loss of $16.1 million for fiscal second-quarter 2010

Intercell to acquire Cytos' platform technology for monoclonal antibody discovery

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News